Clinical, biochemical, and biomolecular aspects of congenital adrenal hyperplasia in a group of Cameroonian children and adolescents
- 20 April 2022
- journal article
- research article
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 35 (6), 777-783
- https://doi.org/10.1515/jpem-2021-0696
Abstract
Objectives Congenital adrenal hyperplasia (CAH) remains one of the most challenging endocrine disorders to diagnose, manage, and treat, especially in Africa where there is lack of neonatal screening program, and limited access to care. Data on biomolecular anomaly are sparse, therefore type of mutations are unknown, increasing management challenges and genetic counseling. The present study aims to describe clinical, biomolecular aspects of a group of Cameroonian patients. Methods We did an observational retrospective study at the pediatric endocrinology unit of the Mother and Child Centre of the Chantal Biya Foundation in Yaounde from May 2013 to December 2019, including all patients diagnosed with CAH. Results We consecutively included 31 patients aged less than 21 years, diagnosed CAH. Median age at diagnosis was 1.71 years (IQR 0.08–2.57 years). Abnormal genitalia was the main complain in 48.4%(n=15). The most prevalent genetic anomaly found in our study population (n=24) was on CYP11, found in 16 patients (66.6%) followed by CYP21A2 mutation found in 8 patients. Homozygous mutation of p.Q356X was found in half of patients with 11 hydroxylase deficiency. This mutation was mostly found in people from semi-Bantu tribes, declared non consanguineous. Conclusions 11 hydroxylase deficiency is the most prevalent form of CAH found in this group of Cameroonian children.Keywords
This publication has 18 references indexed in Scilit:
- Prevalence, clinical characteristics and long-term outcomes of classical 11 β-hydroxylase deficiency (11BOHD) in Turkish population and novel mutations in CYP11B1 geneThe Journal of Steroid Biochemistry and Molecular Biology, 2018
- Congenital adrenal hyperplasiaThe Lancet, 2017
- Congenital Adrenal HyperplasiaJournal of Pediatric and Adolescent Gynecology, 2017
- Clinical, genetic, and structural basis of congenital adrenal hyperplasia due to 11β-hydroxylase deficiencyProceedings of the National Academy of Sciences of the United States of America, 2017
- Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introductionActa Endocrinologica, 2016
- Congenital Adrenal HyperplasiaF1000Research, 2015
- Late clinical presentation of congenital adrenal hyperplasia in older children: findings from national paediatric surveillanceArchives of Disease in Childhood, 2013
- One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort studyThe Lancet Diabetes & Endocrinology, 2013
- Genotype–phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiencyProceedings of the National Academy of Sciences of the United States of America, 2013